PVI
CVAC

Pura Vida Investments’s CureVac CVAC Stock Holding History

Pura Vida Investments’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100,000
Closed -$603K – 102
2022
Q4 		$603K Buy
+100,000
New +$739K 0.03% 161
2021
Q3 		– Sell
-132,300
Closed -$9.72M – 289
2021
Q2 		$9.72M Buy
+132,300
New +$13.2M 0.3% 76

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Pura Vida Investments's CVAC Position: Q1 2023 in Review

Pura Vida Investments sold out of CureVac (CVAC) in Q1 2023, closing a stake of 128,245 shares — an estimated $774K sold.

Pura Vida Investments first reported a position in CVAC in Q4 2022 and held it in 1 quarter. The position peaked at $774K in Q4 2022. 82 funds tracked by Wall St. Rank hold CVAC as of Q1 2023.

  • Pura Vida Investments reported no remaining CureVac position as of Q1 2023 after selling out during the quarter.
  • Pura Vida Investments sold 128,245 CureVac shares in Q1 2023, an estimated $774K.
  • Pura Vida Investments first reported a position in CureVac in Q4 2022 and held it in 1 quarter.
  • Pura Vida Investments's CureVac position peaked at $774K in Q4 2022.
  • 82 funds tracked by Wall St. Rank held CureVac as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.